The invention provides novel heterocyclic compounds, pharmaceutical compositions and methods of treatment that modulate levels of MIF expression and treat disorders associated with high or low levels of MIF expression.
The invention provides novel heterocyclic compounds, pharmaceutical compositions and methods of treatment that modulate levels of MIF expression and treat disorders associated with high or low levels of MIF expression.
NOVEL BENZOFURANONE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME
申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:EP0902022B1
公开(公告)日:2003-07-30
MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION
申请人:MIFCARE
公开号:US20170079958A1
公开(公告)日:2017-03-23
The present invention relates to the use of compounds of general Formula I and pharmaceutically acceptable enantiomers, salts or solvates thereof, for treating pulmonary hypertension in a subject.